Zoeken in deze blog

Kennismaking en Doelstelling

Mijn naam is Brigitte. Ik gebruik medicinale cannabis om medische redenen vanwege chronische pijn, depressies, autisme, adhd en nld met toestemming van mijn behandelend artsen.
Van 2010 tot en met 2018 werd mijn medicinale cannabis vergoed na een lang politiek gevecht. Sinds 2019 heeft de politiek alle manieren van vergoeding stopgezet. Reden: Onvoldoende bewijs van werkzaamheid. Nonsens natuurlijk. In de hele wereld wordt het meer en meer erkend als een medicijn en juist Nederland, ooit een voorloper op dit gebied, zegt nu ineens dat het niet meer werkt. Ik kan mij niet vinden in het huidige cannabisbeleid van de overheid en heb dit blog opgezet om meer aandacht te krijgen voor het belang van deze zaak.

Mijn doelstellingen:

- Medicinale cannabis moet vergoed worden voor mensen die niet zonder kunnen, mits door arts ondersteunt.
- Medicinale cannabis moet gescheiden van het recreatieve gebruik en ook anderszins in de wet komen te staan. Decriminalisering.
- Mensen die medicinaal gebruiken moeten 5 planten thuis kunnen kweken voor eigen gebruik. Of iemand mogen aanwijzen die voor hen kweekt.
- Meer soorten cannabis in de apotheek. Ieder mens reageert uniek. Nu zijn er maar 4 soorten.
- Cannabisolie moet toegestaan worden als geneesmiddel en ook vergoed worden, mits ondersteunt door arts en deze beter werkt dan de cannabis als plant.
- Ook moet cannabisolie voor medicinale indicaties uit het strafrecht.
- Vergoeding voor medicinale cannabis en aanverwante geneesmiddelen moeten vanuit het basispakket via elke zorgverzekeraar verkregen kunnen worden.
- Meer geld voor onderzoeken naar werkzaamheid en manieren om cannabis toe te dienen.

Contact:

Voor pers, media, politici, lotgenoten, instellingen en andere geïnteresseerden ben ik uiteraard altijd beschikbaar. Op het logo staat copyright en overtreding zal worden bestraft. Teksten mogen worden overgenomen, mits er een goede aanklikbare bronvermelding bij gegeven staat.


Brigitte


dinsdag 27 december 2022

>Medicinal Cannabis and Autism Spectrum Disorder and Impulse Control

Medicinal Cannabis and Autism Spectrum Disorder and Impulse Control

Autism spectrum disorder (ASD) is a complex neurological and developmental disorder that affects communication and behavior. Impulse control is the ability to resist the temptation to do something that is not in one's best interests. People with ASD may have difficulty with impulse control, which can lead to problems with social interactions and decision-making.

There has been increasing interest in the use of medicinal cannabis to treat ASD and related conditions, such as impulse control disorders. Cannabis is a plant that contains more than 100 different chemical compounds known as cannabinoids, and some studies have suggested that these compounds may have therapeutic potential for people with ASD.

One of the main cannabinoids found in cannabis is tetrahydrocannabinol (THC), which is the psychoactive compound that is responsible for the "high" associated with recreational cannabis use. THC has been shown to have antipsychotic-like effects in animal studies, and some small human studies have suggested that it may be effective in reducing symptoms of ASD.

Another cannabinoid found in cannabis is cannabidiol (CBD), which is non-psychoactive and has a variety of medicinal properties. Some studies have suggested that CBD may have potential in the treatment of ASD and related conditions, particularly when used in combination with THC. A 2018 study published in the Journal of Psychopharmacology found that CBD was effective in reducing symptoms of anxiety and improving social interaction in children with ASD.

It's worth noting that the use of medicinal cannabis to treat ASD and impulse control disorders is still a relatively new field of research, and more studies are needed to fully understand the potential benefits and risks of using cannabis-based therapies. There are also potential risks to consider when using medicinal cannabis, such as the psychoactive effects of THC and the potential for addiction.

In conclusion, medicinal cannabis may have potential in the treatment of ASD and impulse control disorders, but more research is needed to fully understand its effectiveness and safety. If you are considering using medicinal cannabis to treat these conditions, it's important to consult with a healthcare provider and to carefully consider the potential risks and benefits.

References:

Medicinal Cannabis and Schizophrenia

Medicinal Cannabis and Schizophrenia

Schizophrenia is a serious mental health condition characterized by abnormal thinking, hallucinations, and delusions. It can have a significant impact on daily life and can be difficult to treat. Standard treatments for schizophrenia often include medications and therapy, but these treatments may not be effective for everyone.

In recent years, there has been increasing interest in the use of medicinal cannabis to treat schizophrenia. Cannabis is a plant that contains more than 100 different chemical compounds known as cannabinoids, and some studies have suggested that these compounds may have therapeutic potential for people with schizophrenia.

One of the main cannabinoids found in cannabis is tetrahydrocannabinol (THC), which is the psychoactive compound that is responsible for the "high" associated with recreational cannabis use. THC has been shown to have antipsychotic-like effects in animal studies, and some small human studies have suggested that it may be effective in reducing symptoms of schizophrenia.

Another cannabinoid found in cannabis is cannabidiol (CBD), which is non-psychoactive and has a variety of medicinal properties. Some studies have suggested that CBD may have potential in the treatment of schizophrenia, particularly when used in combination with THC. A 2017 study published in the Journal of Clinical Psychiatry found that CBD was effective in reducing symptoms of psychosis in people with schizophrenia.

It's worth noting that the use of medicinal cannabis to treat schizophrenia is still a relatively new field of research, and more studies are needed to fully understand the potential benefits and risks of using cannabis-based therapies. There are also potential risks to consider when using medicinal cannabis, such as the psychoactive effects of THC and the potential for addiction.

In conclusion, medicinal cannabis may have potential in the treatment of schizophrenia, but more research is needed to fully understand its effectiveness and safety. If you are considering using medicinal cannabis to treat schizophrenia, it's important to consult with a healthcare provider and to carefully consider the potential risks and benefits.

References:

Medicinal Cannabis and Depression

Medicinal Cannabis and Depression

Depression is a common and serious mental health condition that affects millions of people around the world. It's characterized by persistent feelings of sadness, hopelessness, and a lack of interest in activities that were once enjoyable. Depression can have a significant impact on daily life and can be difficult to treat.

In recent years, there has been increasing interest in the use of medicinal cannabis to treat depression. Cannabis is a plant that contains more than 100 different chemical compounds known as cannabinoids, and some studies have suggested that these compounds may have therapeutic potential for people with depression.

One of the main cannabinoids found in cannabis is tetrahydrocannabinol (THC), which is the psychoactive compound that is responsible for the "high" associated with recreational cannabis use. THC has been shown to have antidepressant-like effects in animal studies, and some small human studies have suggested that it may be effective in reducing symptoms of depression.

Another cannabinoid found in cannabis is cannabidiol (CBD), which is non-psychoactive and has a variety of medicinal properties. Some studies have suggested that CBD may have potential in the treatment of depression, particularly when used in combination with THC. A 2018 study published in the Journal of Psychopharmacology found that CBD was effective in reducing symptoms of depression in people with treatment-resistant depression.

It's worth noting that the use of medicinal cannabis to treat depression is still a relatively new field of research, and more studies are needed to fully understand the potential benefits and risks of using cannabis-based therapies. There are also potential risks to consider when using medicinal cannabis, such as the psychoactive effects of THC and the potential for addiction.

In conclusion, medicinal cannabis may have potential in the treatment of depression, but more research is needed to fully understand its effectiveness and safety. If you are considering using medicinal cannabis to treat depression, it's important to consult with a healthcare provider and to carefully consider the potential risks and benefits.

References:

Medicinal Cannabis and Eating Disorders

Medicinal Cannabis and Eating Disorders

Eating disorders are serious mental health conditions characterized by abnormal eating habits that can have a negative impact on physical and mental health. Common types of eating disorders include anorexia nervosa, bulimia nervosa, and binge eating disorder. These conditions can be difficult to treat, and many people with eating disorders struggle to find effective therapies.

In recent years, there has been increasing interest in the use of medicinal cannabis to treat eating disorders. Cannabis is a plant that contains more than 100 different chemical compounds known as cannabinoids, and some studies have suggested that these compounds may have therapeutic potential for people with eating disorders.

One of the main cannabinoids found in cannabis is tetrahydrocannabinol (THC), which is the psychoactive compound that is responsible for the "high" associated with recreational cannabis use. THC has been shown to have appetite-stimulating effects, which may be helpful for people with anorexia nervosa, a type of eating disorder characterized by an abnormal fear of weight gain and a refusal to maintain a healthy body weight.

Another cannabinoid found in cannabis is cannabidiol (CBD), which is non-psychoactive and has a variety of medicinal properties. Some studies have suggested that CBD may have potential in the treatment of eating disorders, particularly binge eating disorder. A 2018 study published in the Journal of Psychopharmacology found that CBD was effective in reducing binge eating behaviors in people with binge eating disorder.

It's worth noting that the use of medicinal cannabis to treat eating disorders is still a relatively new field of research, and more studies are needed to fully understand the potential benefits and risks of using cannabis-based therapies. There are also potential risks to consider when using medicinal cannabis, such as the psychoactive effects of THC and the potential for addiction.

In conclusion, medicinal cannabis may have potential in the treatment of eating disorders, but more research is needed to fully understand its effectiveness and safety. If you are considering using medicinal cannabis to treat an eating disorder, it's important to consult with a healthcare provider and to carefully consider the potential risks and benefits.

References:

woensdag 24 juni 2015

Nieuwe update, pagina's: Welke soort wiet voor welke klacht

Nieuw op dit blog. Een keurig overzicht welke soorten wiet geschikt zijn voor welke klacht. Te vinden links boven in aparte pagina's.

Volg mij ook facebook en twitter


Facebookpagina van de eerste vrouw in Nederland die wiet vergoed heeft gekregen van de overheid na een lange politieke...
Posted by Medicinale Cannabis on Wednesday, June 24, 2015